amifostine anhydrous has been researched along with Breast Diseases in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Breast Diseases: Pathological processes of the BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koukourakis, MI | 1 |
| Tsoutsou, PG | 1 |
| Abatzoglou, IM | 1 |
| Sismanidou, K | 1 |
| Giatromanolaki, A | 1 |
| Sivridis, E | 1 |
1 other study available for amifostine anhydrous and Breast Diseases
| Article | Year |
|---|---|
Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.
Topics: Adult; Aged; Amifostine; Breast Diseases; Breast Neoplasms; Female; Humans; Mastectomy, Segmental; M | 2009 |